Cochrane · systematic review · CD008613
Hormone replacement therapy for women with type 1 diabetes mellitus
Mackay, L, Kilbride, L, Adamson, KA, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
Metabolic and Endocrine DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
2
No studies
4
Included studies
NR
No studies 4 · 66.7%Ungraded 0 · 0%Very low 2 · 33.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: peri‐ or postmenopausal women with type 1 diabetes mellitus
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Diabetes and non‐diabetes related morbidity | no estimate extracted | NR | No studies |
Death from any cause | no estimate extracted | NR | No studies |
Adverse effects [ | no estimate extracted | 1 study · 56 participants | Very low Downgraded: risk of bias, indirectness |
Health‐related quality of life | no estimate extracted | NR | No studies |
Glycaemic control (fructosamine levels) [ | no estimate extracted | 1 study · 56 participants | Very low Downgraded: risk of bias, indirectness |
Economic data | no estimate extracted | NR | No studies |